NKCL Bio Group Inc. won the ‘2023 Customer Love Brand Grand Prize’ in the immune care platform category.

|Growing into a global top bio company in the K-Bio field through immune care platform services

 

On May 16th, NKCL Bio Group Inc., a bio company that researches and develops NK immune cell therapy using NK (Natural Killer) cells based on its excellent technology, held a ' Won the grand prize in the immune care platform category at the 2023 Customer Love Brand Awards.

 

NKCL Bio Group, as a brand specializing in 'personalized immune care', is leading the popularization of NK cell therapy effective for cancer treatment and immunity enhancement through differentiated immune cell culture technology, and through immune care platform service, K-Bio The ultimate goal is to become a global top bio company in the field.

 

NKCL Bio Group, as a representative company of Korea's immune brand, has patents and original technology for medium addition kits and culture methods for NK cell culture with the goal of 'save one life, save one soul', and NK IMMUNE WATER (Bottled Water), NK IMMNE SERIES (Cosmetics), and RK-NKTM ACS (Automatic Cultivator for One Person), various immune care products and bio programs are being introduced, expanding global marketing activities.

In particular, RK-NK100, produced with NKCCM, a genetically recombinant protein in which NKCL's technology is concentrated, is a personalized skin immunity solution that maximizes the effect by using the nano spot device, a personal HIFU equipment.

 

An official from NKCL Bio Group Co., Ltd. said, “We are delighted to be honored with the 2023 Customer Love Brand Grand Prize thanks to the support and love of many customers.” We will continue to work harder to build a platform.”

[Source] JoongAng Ilbo in America: https://news.koreadaily.com/2023/05/25/economy/business/20230525180005396.html